Pioneer in development of carbohydrate based drug. Our platform technology delivers structurally defined synthetic heparin scalable to replace the multibillion dollar animal based anticoagulant heparin. Our services include heparan sulfate microarray and a novel highly sensitive LC-MS based detection of heparan sulfate from body fluids and tissues.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 617 Hutton Street,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Raleigh, North Carolina
Glycan Therapeutics Questions
Glycan Therapeutics's website is http://www.glycantherapeutics.com
Glycan Therapeutics's LinkedIn profile is https://www.linkedin.com/company/glycan-therapeutics
Glycan Therapeutics has
11 employees.
View email and phone details for 11
employees at Glycan Therapeutics.
Glycan Therapeutics's industry is
Pharmaceutical Manufacturing
Glycan Therapeutics's top competitors are
Tenax Therapeutics,
Glycan Therapeutics,
Tregtherapeutics Inc.,
Incyclix Bio,
Glycomantra,
Glycan,
Natglycan, Llc,
Grid Therapeutics,
Madera Therapeutics,
Lectenz Bio.
Glycan Therapeutics's categories are Pharmaceutical Manufacturing
Glycan Therapeutics's founding year is 2013
